Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 2017 - 2024 of 11616 results
NYC Council Amends Salary Range Transparency Law; Delays Implementation Date
May 3, 2022| Blog| Viewpoint
Determining Entity Status Before the United States and Patent Trademark Office: Large, Small, or Micro?
May 3, 2022| Blog| Viewpoint
Massachusetts for ARPA-H
May 3, 2022| Blog| Viewpoint
OIG Says that Increasing Use of Biosimilars Could Reduce Part D Spending
May 2, 2022| Blog| Viewpoint
Sales Projections and a “Litigation Risk Multiplier” Are Fair Game When Assessing Reasonable Royalty Damages
April 29, 2022| Blog| Viewpoint
ML Strategies Energy & Sustainability Washington Update — May 2022
April 29, 2022| Blog| Viewpoint
1st Circuit Overturns Its Bar On Some Types Of CWA Citizen Suits
April 29, 2022| News
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.